1. Nat Commun. 2018 May 3;9(1):1790. doi: 10.1038/s41467-018-04098-8.

Chemokines cooperate with TNF to provide protective anti-viral immunity and to 
enhance inflammation.

Alejo A(1), Ruiz-Argüello MB(1)(2), Pontejo SM(3)(4), Fernández de Marco 
MDM(3)(5), Saraiva M(6)(7), Hernáez B(3), Alcamí A(8)(9).

Author information:
(1)Centro de Investigación en Sanidad Animal; Instituto Nacional de 
Investigación y Tecnología Agraria y Alimentaria, Valdeolmos, Madrid, 28130, 
Spain.
(2)Progenika Biopharma, 48160, Derio, Spain.
(3)Centro de Biología Molecular Severo Ochoa (Consejo Superior de 
Investigaciones Científicas and Universidad Autónoma de Madrid), Cantoblanco, 
Madrid, 28049, Spain.
(4)National Institutes of Health, Bethesda, Maryland, 20892, USA.
(5)Animal & Plant Health Agency, Addlestone, Surrey, KT15 3NB, UK.
(6)Department of Medicine, University of Cambridge, Addenbrooke's Hospital, 
Cambridge, CB2 2QQ, United Kingdom.
(7)Institute for Molecular and Cell Biology, 4200-135, Porto, Portugal.
(8)Centro de Biología Molecular Severo Ochoa (Consejo Superior de 
Investigaciones Científicas and Universidad Autónoma de Madrid), Cantoblanco, 
Madrid, 28049, Spain. aalcami@cbm.csic.es.
(9)Department of Medicine, University of Cambridge, Addenbrooke's Hospital, 
Cambridge, CB2 2QQ, United Kingdom. aalcami@cbm.csic.es.

The role of cytokines and chemokines in anti-viral defense has been 
demonstrated, but their relative contribution to protective anti-viral responses 
in vivo is not fully understood. Cytokine response modifier D (CrmD) is a 
secreted receptor for TNF and lymphotoxin containing the smallpox virus-encoded 
chemokine receptor (SECRET) domain and is expressed by ectromelia virus, the 
causative agent of the smallpox-like disease mousepox. Here we show that CrmD is 
an essential virulence factor that controls natural killer cell activation and 
allows progression of fatal mousepox, and demonstrate that both SECRET and TNF 
binding domains are required for full CrmD activity. Vaccination with 
recombinant CrmD protects animals from lethal mousepox. These results indicate 
that a specific set of chemokines enhance the inflammatory and protective 
anti-viral responses mediated by TNF and lymphotoxin, and illustrate how viruses 
optimize anti-TNF strategies with the addition of a chemokine binding domain as 
soluble decoy receptors.

DOI: 10.1038/s41467-018-04098-8
PMCID: PMC5934441
PMID: 29724993 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.